WO2007121748A3 - Composition améliorée de colle à la fibrine et utilisation de cette dernière - Google Patents

Composition améliorée de colle à la fibrine et utilisation de cette dernière Download PDF

Info

Publication number
WO2007121748A3
WO2007121748A3 PCT/DK2007/000188 DK2007000188W WO2007121748A3 WO 2007121748 A3 WO2007121748 A3 WO 2007121748A3 DK 2007000188 W DK2007000188 W DK 2007000188W WO 2007121748 A3 WO2007121748 A3 WO 2007121748A3
Authority
WO
WIPO (PCT)
Prior art keywords
sealant composition
fibrin sealant
improved fibrin
improved
wound healing
Prior art date
Application number
PCT/DK2007/000188
Other languages
English (en)
Other versions
WO2007121748A2 (fr
Inventor
Niels Erik Holm
Original Assignee
Niels Erik Holm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Niels Erik Holm filed Critical Niels Erik Holm
Priority to EP07722567A priority Critical patent/EP2010238A2/fr
Priority to JP2009505722A priority patent/JP2009534058A/ja
Priority to CA002648552A priority patent/CA2648552A1/fr
Publication of WO2007121748A2 publication Critical patent/WO2007121748A2/fr
Publication of WO2007121748A3 publication Critical patent/WO2007121748A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0042—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

Le processus de guérison des plaies peut être amélioré par l'ajout d'une colle à la fibrine. En fonction de la composition de colle et de la procédure d'application, le processus de guérison des plaies et la régénération tissulaire peuvent être accélérés davantage. Cette invention concerne une composition de colle améliorée et l'utilisation de cette dernière.
PCT/DK2007/000188 2006-04-20 2007-04-20 Composition améliorée de colle à la fibrine et utilisation de cette dernière WO2007121748A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP07722567A EP2010238A2 (fr) 2006-04-20 2007-04-20 Composition améliorée de colle à la fibrine et utilisation de cette dernière
JP2009505722A JP2009534058A (ja) 2006-04-20 2007-04-20 改良フィブリンシーラント組成物及びその用途
CA002648552A CA2648552A1 (fr) 2006-04-20 2007-04-20 Composition amelioree de colle a la fibrine et utilisation de cette derniere

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200600545 2006-04-20
DKPA200600545 2006-04-20

Publications (2)

Publication Number Publication Date
WO2007121748A2 WO2007121748A2 (fr) 2007-11-01
WO2007121748A3 true WO2007121748A3 (fr) 2008-05-29

Family

ID=38456483

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK2007/000188 WO2007121748A2 (fr) 2006-04-20 2007-04-20 Composition améliorée de colle à la fibrine et utilisation de cette dernière

Country Status (4)

Country Link
EP (1) EP2010238A2 (fr)
JP (1) JP2009534058A (fr)
CA (1) CA2648552A1 (fr)
WO (1) WO2007121748A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011112955A1 (de) 2011-09-13 2013-03-14 Medizinische Hochschule Hannover Verfahren zur Herstellung eines biologischen Gewebekonstrukts und Verwendung spezifisch gewonnener autologer Zellen
BR102014011436A8 (pt) * 2014-05-12 2018-01-09 Univ Estadual Paulista Julio De Mesquita Filho selante de fibrina para uso tópico, método de formação do mesmo e seu uso

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4532134A (en) * 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
US5773033A (en) * 1995-01-23 1998-06-30 The Regents Of The University Of California Fibrinogen/chitosan hemostatic agents
WO1999025782A2 (fr) * 1997-11-17 1999-05-27 Haemacure Corporation Agents de scellement ou adhesifs comprenant un materiau derive d'acide hyaluronique
US20030147878A1 (en) * 1991-06-17 2003-08-07 Biovitrum Ab, A Swedish Corporation Tissue treatment compositions

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4532134A (en) * 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
US20030147878A1 (en) * 1991-06-17 2003-08-07 Biovitrum Ab, A Swedish Corporation Tissue treatment compositions
US5773033A (en) * 1995-01-23 1998-06-30 The Regents Of The University Of California Fibrinogen/chitosan hemostatic agents
WO1999025782A2 (fr) * 1997-11-17 1999-05-27 Haemacure Corporation Agents de scellement ou adhesifs comprenant un materiau derive d'acide hyaluronique
US6503527B1 (en) * 1997-11-17 2003-01-07 Haemacure Corporation Fibrin sealants or adhesives comprising a hyaluronic acid derivative material

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GRANT ET AL: "The co-application of sprayed cultured autologous keratinocytes and autologous fibrin sealant in a porcine wound model", BRITISH JOURNAL OF PLASTIC SURGERY, CHURCHILL LIVINGSTONE, GB, vol. 55, no. 3, April 2002 (2002-04-01), pages 219 - 227, XP005316172, ISSN: 0007-1226 *

Also Published As

Publication number Publication date
CA2648552A1 (fr) 2007-11-01
EP2010238A2 (fr) 2009-01-07
WO2007121748A2 (fr) 2007-11-01
JP2009534058A (ja) 2009-09-24

Similar Documents

Publication Publication Date Title
AU2016204344A1 (en) Improved methods and compositions for wound healing
WO2008060374A3 (fr) Procédés et compositions utiles pour une cicatrisation de plaie chez les diabétiques
WO2007092622A3 (fr) Compositions et méthodes pour le traitement d'os
IL233634A0 (en) Methods, compositions and kits for treating medical conditions
WO2007059513A3 (fr) Compositions et procedes de modulation d’hemostase
EP1759973B8 (fr) Objet mouvant et méthode de control associée
WO2008127290A3 (fr) Compositions d'alginate et d'alginate-lyase et procédés d'utilisation
WO2007056681A3 (fr) Procedes d'administration d'agents hypoglycemiques
WO2007130697A8 (fr) Anticorps anti-ephb4 et procedes qui les utilisent
WO2008060705A3 (fr) Anticorps anti-dll4 et leurs procédés d'utilisation
WO2008034013A3 (fr) Dispositifs médicaux et procédés de réalisation desdits dispositifs
WO2007127834A3 (fr) Compositions et leurs méthodes d'élaboration
WO2008100805A3 (fr) Anticorps anti-robo4 et utilisations de ceux-ci
WO2008036238A3 (fr) Utilisation de modulateurs lxr dans la prévention et le traitement du vieillissement cutané
WO2010019753A3 (fr) Échafaudages tissulaires
EP1859793A4 (fr) Nouvelle utilisation combinee d'un compose de sulfonamide
EP1868628A4 (fr) Composes, compositions et methodes de traitement des infections a poxvirus
WO2006003492A3 (fr) Compositions et methodes de traitement d'infections pathologiques
WO2008054676A3 (fr) Dispositifs médicaux et méthodes d'utilisation correspondantes
WO2008064916A3 (fr) Moyen de traitement de fuites vasculaires
WO2008045507A3 (fr) Composés de tétracycline substitués utilisés pour le traitement d'infections à bacillus anthracis
WO2010072787A3 (fr) Composition et méthode de traitement d'états pathologiques cutanés
WO2008112192A3 (fr) Anticorps epha3 utilises dans le traitement des tumeurs solides
WO2007127506A3 (fr) Anticorps anti-ephrinb2 et procédés les utilisant
WO2008002855A8 (fr) Procédés de traitement des blessures

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07722567

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2648552

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2009505722

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007722567

Country of ref document: EP